Type
 
											Sandwich ELISA, HRP-labelled antibody
												Description
 
											The RIS002R Human Osteocalcin ELISA Immunoenzymetric assay for the measurement of intact human osteocalcin (OST) in serum. It is intended for research use only.
												Applications
 
											Serum
												Sample Requirements
 
											25 µl/well
												Shipping
 
											On blue ice packs.  Upon receipt, store the product at the temperature recommended below.
												Storage/Expiration
 
											Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).
															Calibration Curve
 
														
												Calibration Range
 
											1.56–75 ng/ml
												Limit of Detection
 
											0.08 ng/ml
												Intra-assay (Within-Run)
 
											CV < 6%
												Inter-assay (Run-to-Run)
 
											CV < 6%
								
							 
							
								
												Features
 
											
- RUO
- calibration range 1.56-75 ng/ml
- limit of detection 0.08ng/ml
- quality controls
Research topic
 
											Bone and cartilage metabolism
												Summary
 
											Biological activities
Osteocalcin or bone Gla protein (B.G.P) is the major non-collagen protein of the bone matrix. It has a molecular weight of 5800 Da and contains 49 amino-acids, including 3 residues of gamma carboxyl glutamic acid. Osteocalcin is synthesized in the bone by the osteoblasts. After production, it is partly incorporated in the bone matrix and the rest is found in the blood circulation. The exact physiological function of osteocalcin is still unclear. A large number of studies show that the circulating levels of osteocalcin reflect the rate of bone formation.
Clinical application
The determination of the blood levels of osteocalcin is valuable for :
− The identification of women at risk of developing osteoporosis
− Monitoring bone metabolism during the perimenopause and postmenopause
− Monitoring bone metabolism during hormone replacement therapy and treatment of premenopausal women with LH-RH agonists
− Monitoring bone metabolism in patients with growth hormone deficiency, hypothyroidism, hyperthyroidism, chronic renal failure.
								
							 
							
	
				Find documents for the lot
				
				
						
						Example Instructions for Use (RUO)
						
					
							Example Instructions for Use (RUO)
							
						
					
						
						Safety Information (RUO)
						
					
							MSDS (RUO)